Canaquest Medical Corp Stock Gross Profit
CANQF Stock | USD 0.03 0.00 0.00% |
CanaQuest Medical Corp fundamentals help investors to digest information that contributes to CanaQuest Medical's financial success or failures. It also enables traders to predict the movement of CanaQuest Pink Sheet. The fundamental analysis module provides a way to measure CanaQuest Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CanaQuest Medical pink sheet.
CanaQuest |
CanaQuest Medical Corp Company Gross Profit Analysis
CanaQuest Medical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, CanaQuest Medical Corp reported 0.0 of gross profit. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
CanaQuest Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CanaQuest Medical's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CanaQuest Medical could also be used in its relative valuation, which is a method of valuing CanaQuest Medical by comparing valuation metrics of similar companies.CanaQuest Medical is currently under evaluation in gross profit category among its peers.
CanaQuest Fundamentals
Return On Asset | -6.33 | |||
Current Valuation | 2.54 M | |||
Shares Outstanding | 20.14 M | |||
Shares Owned By Insiders | 53.90 % | |||
EBITDA | (999.47 K) | |||
Net Income | (1.1 M) | |||
Cash And Equivalents | 8 | |||
Current Ratio | 0.08 X | |||
Book Value Per Share | (0.05) X | |||
Cash Flow From Operations | 27.54 K | |||
Earnings Per Share | (0.06) X | |||
Target Price | 0.73 | |||
Beta | 2.37 | |||
Market Capitalization | 3.22 M | |||
Total Asset | 110.32 K | |||
Z Score | -29.7 | |||
Net Asset | 110.32 K |
About CanaQuest Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CanaQuest Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanaQuest Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanaQuest Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CanaQuest Pink Sheet
CanaQuest Medical financial ratios help investors to determine whether CanaQuest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanaQuest with respect to the benefits of owning CanaQuest Medical security.